Last updated on November 2, 2025
No. In Belarus, pharmaceutical production without a GMP (Good Manufacturing Practice) certificate is prohibited. Compliance with GMP standards is a legal requirement for all manufacturers to ensure product quality, safety, and regulatory approval.
Why Belarus Insists on GMP
Pharmaceuticals are not just another commodity—they are life-saving products that demand the highest standards of safety and quality. Belarus, like most countries, enforces strict rules to protect public health. At the heart of these rules is Good Manufacturing Practice (GMP), a globally recognized system that governs how medicines are produced, packaged, and controlled.
GMP is not optional in Belarus. It is embedded in the country’s technical regulations and licensing requirements. These standards apply to all types of medicines manufactured in Belarus, whether for domestic use or export, and they align with international norms such as PIC/S and EU GMP guidelines.
What GMP Really Means
GMP is more than a certificate—it’s a comprehensive framework. It requires manufacturers to:
- Maintain hygienic and controlled environments to prevent contamination.
- Validate all critical processes to ensure consistency.
- Keep detailed records for traceability and accountability.
- Train personnel in quality assurance and safety protocols.
- Implement systems for handling complaints and recalls.
Without GMP, the risks are enormous: contaminated products, inaccurate dosing, and compromised patient safety. That’s why Belarus mandates GMP certification as a condition for obtaining a pharmaceutical production license.
The Licensing Process Explained
Producing medicines in Belarus requires a special license for pharmaceutical activity, issued by the Ministry of Health. This license is not granted automatically—it involves a multi-step process designed to verify compliance with GMP standards:
- Application Submission
The manufacturer submits an application to the Ministry of Health, including detailed information about the company, production facilities, and intended product range. - Document Review
Authorities review technical documentation, including quality assurance systems, process validation reports, and staff training records. Proof of GMP compliance is mandatory at this stage. - On-Site Inspection
Inspectors from the State Center for Drug Expertise and Quality Control visit the production site to verify that facilities meet GMP requirements. This includes checks on equipment, hygiene, storage conditions, and documentation practices. - Issuance of License
If the inspection confirms compliance, the Ministry of Health issues the license. The license is valid for a fixed term and subject to renewal, which requires continued GMP compliance. - Ongoing Monitoring
Even after licensing, manufacturers face periodic audits and inspections. Any deviation from GMP standards can lead to suspension or revocation of the license.
This rigorous process ensures that only qualified manufacturers operate in Belarus, protecting consumers and maintaining the integrity of the pharmaceutical market.
Why Such Strict Oversight?
Belarus’s approach reflects a commitment to public health and global competitiveness. GMP compliance ensures that Belarusian medicines meet international benchmarks, enabling exports and fostering trust among consumers. It also reduces the risk of costly recalls and reputational damage for manufacturers.
What Happens If You Skip GMP?
Producing pharmaceuticals without GMP certification is a serious violation. Consequences include:
- License revocation for the manufacturer.
- Administrative fines and potential criminal liability for responsible officials.
- Market withdrawal of non-compliant products.
- Loss of export opportunities and reputational harm.
In short, skipping GMP is not just illegal—it’s a business risk that can shut down operations entirely.
Cultural and Practical Context
Belarus has invested heavily in upgrading its pharmaceutical industry. The government supports modernization projects and encourages certification under GMP standards recognized internationally. Today, most Belarusian manufacturers operate under GMP, reflecting the country’s ambition to compete in global markets.
Looking Ahead
Belarus continues to strengthen its regulatory framework, aligning with Eurasian Economic Union standards and international best practices. For manufacturers, GMP compliance is not just a legal checkbox—it’s a strategic necessity. For consumers, it means confidence that medicines are safe, effective, and produced under rigorous controls.
See more on Belarus
Sources
Resolution of the Ministry of Health of the Republic of Belarus on Licensing and GMP Requirements
https://minzdrav.gov.by/ru/dlya-spetsialistov/normativno-pravovaya-baza/tekhnicheskie-normativnye-pravovye-akty/teksty-tekhnicheskikh-normativnykh-aktov
Ongoing